Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Tienopiridina derivado")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 503

  • Page / 21
Export

Selection :

  • and

Inhibiteurs de la pompe à protons et clopidogrel: que faire en pratique ? = Proton pump inhibitors and clopidogrel: What are we doing now?BRETAGNE, Jean-François.La Presse médicale (1983). 2010, Vol 39, Num 11, pp 1122-1125, issn 0755-4982, 4 p.Article

Clopidogrel response variability: Current status and future directionsFERREIRO, José Luis; ANGIOLILLO, Dominick J.Thrombosis and haemostasis. 2009, Vol 102, Num 1, pp 7-14, issn 0340-6245, 8 p.Article

Desensitization to clopidogrel: a tailor-made protocolBARREIRA, P; CADINHA, S; MALHEIRO, D et al.European annals of allergy and clinical immunology. 2014, Vol 46, Num 1, pp 53-55, issn 1764-1489, 3 p.Article

High residual platelet reactivity on standard clopidogrel maintenance dose predicts increased responsiveness to the double-standard dose in an assay-dependent mannerOESTREICH, Julie H; STEINHUBL, Steven R; FERRARIS, Suellen P et al.Thrombosis and haemostasis. 2011, Vol 105, Num 5, pp 927-930, issn 0340-6245, 4 p.Article

Pharmacogenetics and Clopidogrel Response in Patients Undergoing Percutaneous Coronary InterventionsBEITELSHEES, A. L; HORENSTEIN, R. B; VESELY, M. R et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 3, pp 455-459, issn 0009-9236, 5 p.Article

Safety of Clopidogrel in Older Patients: A Nonrandomized, Parallel-Group, Controlled, Two-Centre StudyCAY, Serkan; CAGIRCI, Goksel; AYDOGDU, Sinan et al.Drugs & aging. 2011, Vol 28, Num 2, pp 119-129, issn 1170-229X, 11 p.Article

Association of genetic variants in CYP2C19 and adverse clinical outcomes after treatment with clopidogrel: An updated meta-analysisYAN PING LIU; PAN PAN HAO; MING XIANG ZHANG et al.Thrombosis research. 2011, Vol 128, Num 6, pp 593-594, issn 0049-3848, 2 p.Article

A Possible Mechanism for the Differences in Efficiency and Variability of Active Metabolite Formation from Thienopyridine Antiplatelet Agents, Prasugrel and ClopidogrelHAGIHARA, Katsunobu; KAZUI, Miho; KURIHARA, Atsushi et al.Drug metabolism and disposition. 2009, Vol 37, Num 11, pp 2145-2152, issn 0090-9556, 8 p.Article

Genetic Determinants of Response to Clopidogrel and Cardiovascular EventsSIMON, Tabassome; VERSTUYFT, Celine; MARY-KRAUSE, Murielle et al.The New England journal of medicine. 2009, Vol 360, Num 4, pp 363-375, issn 0028-4793, 13 p.Article

Perioperative Clopidogrel Is Seven Days Enough?GRUJIC, Dejan; MARTIN, David.The American surgeon. 2009, Vol 75, Num 10, pp 909-913, issn 0003-1348, 5 p.Conference Paper

Clopidogrel pretreatment abolishes increase of PAI-1 after coronary stent implantationKATSAROS, Katharina M; KASTL, Stefan P; HUBER, Kurt et al.Thrombosis research. 2008, Vol 123, Num 1, pp 79-84, issn 0049-3848, 6 p.Article

Clopidogrel and Bleeding after General Surgery ProceduresOZAO-CHOY, Junko; TAMMARO, Yolanda; FRADIS, Martin et al.The American surgeon. 2008, Vol 74, Num 8, pp 721-725, issn 0003-1348, 5 p.Conference Paper

Determination of residual antiplatelet activity of clopidogrel before neuraxial injectionsBENZON, H. T; MCCARTHY, R. J; BENZON, H. A et al.British journal of anaesthesia. 2011, Vol 107, Num 6, pp 966-971, issn 0007-0912, 6 p.Article

Reversal of Clopidogrel-Induced Bleeding with rFVIIa in Healthy Subjects: A Randomized, Placebo-Controlled, Double-Blind, Exploratory StudySKOLNICK, Brett E; SHENOUDA, Magdy; KHUTORYANSKY, Naum M et al.Anesthesia and analgesia. 2011, Vol 113, Num 4, pp 703-710, issn 0003-2999, 8 p.Article

Effects of CYP2C19 Genotype on Outcomes of Clopidogrel TreatmentPARE, Guillaume; MEHTA, Shamir R; YUSUF, Salim et al.The New England journal of medicine. 2010, Vol 363, Num 18, pp 1704-1714, issn 0028-4793, 11 p.Article

Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO StudyKOHLI, Payal; WALLENTIN, Lars; OTO, Ali et al.Circulation (New York, N.Y.). 2013, Vol 127, Num 6, pp 673-680, issn 0009-7322, 8 p.Article

Postpolypectomy bleeding in patients undergoing colonoscopy on uninterrupted clopidogrel therapySINGH, Mandeep; MEHTA, Nilesh; MURTHY, Uma K et al.Gastrointestinal endoscopy (Print). 2010, Vol 71, Num 6, pp 998-1005, issn 0016-5107, 8 p.Article

Clinical Pharmacokinetics of Clopidogrel and Its Metabolites in Patients with Cardiovascular DiseasesKARAZNIEWICZ-ŁADA, Marta; DANIELAK, Dorota; BURCHARDT, Paweł et al.Clinical pharmacokinetics. 2014, Vol 53, Num 2, pp 155-164, issn 0312-5963, 10 p.Article

CYP2C19 gene variants cut-off levels for on-clopidogrel platelet aggregationWIWANITKIT, Viroj.Thrombosis research. 2012, Vol 129, Num 2, issn 0049-3848, p. 212Article

Solubility of Clopidogrel Hydrogen Sulfate (Form II) in Different SolventsLIANGCHENG SONG; MINXU LI; JUNBO GONG et al.Journal of chemical and engineering data (Print). 2010, Vol 55, Num 9, pp 4016-4018, issn 0021-9568, 3 p.Article

Randomised, double-blind trial on the value of tapered discontinuation of clopidogrel maintenance therapy after drug-eluting stent implantation: Intracoronary Stenting and Antithrombotic Regimen: CAUTION in Discontinuing Clopidogrel Therapy - ISAR-CAUTIONFIEDLER, K. Anette; MEHILLI, Julinda; SCHULZ, Stefanie et al.Thrombosis and haemostasis. 2014, Vol 111, Num 6, pp 1041-1049, issn 0340-6245, 9 p.Article

Prasugrel use in a patient allergic to clopidogrel: Effect of a drug shortage on selection of dual antiplatelet therapyFELIX-GETZIK, Erika; SYLVIA, Lynne M.American journal of health-system pharmacy. 2013, Vol 70, Num 6, pp 511-513, issn 1079-2082, 3 p.Article

A Risk―Benefit Assessment of Prasugrel, Clopidogrel, and Genotype-Guided Therapy in Patients Undergoing Percutaneous Coronary InterventionGUZAUSKAS, G. F; HUGHES, D. A; BRADLEY, S. M et al.Clinical pharmacology and therapeutics. 2012, Vol 91, Num 5, pp 829-837, issn 0009-9236, 9 p.Article

Clinical effects and outcomes with new P2Y12 inhibitors in ACSCOLLET, Jean-Philippe; O'CONNOR, Stephen.Fundamental & clinical pharmacology. 2012, Vol 26, Num 1, pp 16-18, issn 0767-3981, 3 p.Conference Paper

Clopidogrel Effectively Suppresses Endothelial Microparticle Generation Induced by Indoxyl Sulfate via Inhibition of the p38 Mitogen-Activated Protein Kinase PathwayRYU, Jung-Hwa; KIM, Seung-Jung.Blood purification. 2011, Vol 32, Num 3, pp 186-194, issn 0253-5068, 9 p.Article

  • Page / 21